Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 4/20 | 0.41 |
| ▸ | FNTB | P49356 | 4/20 | 0.41 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11455957 | 0.97 | PTPN1 (0.44) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL11125479 | 0.92 | LMNA (0.51) | LMNAKMT2APTPN1ALDH1A1MME | |
| SCHEMBL10653360 | 0.89 | LMNA (0.48) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL10657196 | 0.89 | LMNA (0.48) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL11129156 | 0.89 | HTT (0.39) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL10654417 | 0.87 | LMNA (0.47) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL10657996 | 0.87 | LMNA (0.47) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL10653336 | 0.86 | FNTA (0.49) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL10655585 | 0.86 | FNTA (0.49) | LMNAKMT2AFNTAFNTBPGGT1B | |
| SCHEMBL11124423 | 0.84 | LMNA (0.42) | LMNAFNTAFNTBPTPN1MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4216208-A | N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity | PROTER S.P.A. (IT) | 1980-08-05 | — | — | US | disclosed |